Zimmer Biomet Holdings Inc ZBH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ZBH is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $2,080.72
- Day Range
- $2,015.00–2,015.00
- 52-Week Range
- $1,850.11–2,483.11
- Bid/Ask
- $1,850.15 / $2,015.00
- Market Cap
- $414.54 Bil
- Volume/Avg
- 119 / 64
Key Statistics
- Price/Earnings (Normalized)
- 15.27
- Price/Sales
- 3.25
- Dividend Yield (Trailing)
- 0.63%
- Dividend Yield (Forward)
- 0.88%
- Total Yield
- 2.93%
Company Profile
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Core
- Total Number of Employees
- 18,000
- Website
- https://www.zimmerbiomet.com
Competitors
Valuation
|
Metric
|
ZBH
|
JNJ
|
SNN
|
|---|---|---|---|
Price/Earnings (Normalized) | 15.27 | 13.91 | 13.90 |
Price/Book Value | 1.98 | 5.00 | 2.12 |
Price/Sales | 3.25 | 4.09 | 1.99 |
Price/Cash Flow | 12.56 | 15.73 | 11.75 |
Price/Earnings
ZBH
JNJ
SNN
Financial Strength
|
Metric
|
ZBH
|
JNJ
|
SNN
|
|---|---|---|---|
Quick Ratio | 0.66 | 0.84 | 0.67 |
Current Ratio | 1.66 | 1.17 | 1.77 |
Interest Coverage | 5.89 | 23.57 | 2.84 |
Quick Ratio
ZBH
JNJ
SNN
Profitability
|
Metric
|
ZBH
|
JNJ
|
SNN
|
|---|---|---|---|
Return on Assets (Normalized) | 6.15% | 12.64% | 7.27% |
Return on Equity (Normalized) | 10.57% | 31.72% | 13.79% |
Return on Invested Capital (Normalized) | 8.26% | 20.11% | 9.92% |
Return on Assets
ZBH
JNJ
SNN
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Lbkpvrrj | Kpzzfz | $180.4 Bil | |||
| Stryker Corp
SYK
| Xzxmxrcy | Kdytc | $131.4 Bil | |||
| Boston Scientific Corp
BSX
| Llnscxsd | Zjqgkj | $112.9 Bil | |||
| Medtronic PLC
MDT
| Ckgrgmjt | Dlnrfjt | $106.3 Bil | |||
| Edwards Lifesciences Corp
EW
| Pwdtltlthj | Vfbvm | $52.6 Bil | |||
| DexCom Inc
DXCM
| Pmxyckhv | Xgfhp | $45.9 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Rllnsgpz | Xlkcb | $24.3 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Rtvrlbdtt | Vjq | $22.1 Bil | |||
| Steris PLC
STE
| Wtxscgh | Dxhywz | $21.6 Bil | |||
| Align Technology Inc
ALGN
| Cncrkzps | Gvtlvg | $19.3 Bil |